$TRVI
Trevi Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New Haven, CT
TRVI chart
What traders are saying about $TRVI
Latest postsTrevi Therapeutics, Inc. news
- Trevi Therapeutics advances Phase 3 trials for ...
Pluang ·
- Trevi Therapeutics (TRVI) After Fresh Loss Figures Is The Undervalued Story Still Intact
Simply Wall St ·
- Trevi Therapeutics Inc (TRVI) Q3 2026 Earnings Call Highlights: Strong Cash Position, FDA ...
Yahoo Finance ·
- Trevi Therapeutics (TRVI) Q3 2026 Earnings Call Transcript
fool.com ·
- Trevi Therapeutics (TRVI) Launches OCEAN-1 and OCEAN-2 Trials, Eyes Data in 2027-2028
GuruFocus ·
- Trevi Therapeutics stock advances as Q3 loss widens, trials progress
ad-hoc-news.de ·
- What Trevi Therapeutics (TRVI) Said on Its Q3 Earnings Call
marketbeat.com ·
- Trevi Therapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Trevi Therapeutics Q3 2026 Earnings Call Transcript
Benzinga ·
- Trevi Therapeutics Q3 Loss Widens
www.marketscreener.com ·
- Form 8K Trevi Therapeutics Inc For: 9 November By Investing.com
Investing.com Canada ·
- Trevi Therapeutics (TRVI) Reports In-Line Q3 EPS
StreetInsider ·
Trevi Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$42.8M | -$47.9M | -$29.1M | -$29.2M |
| Diluted EPS | $-0.32 | $-0.47 | $-0.29 | $-0.45 |
| Total assets (year end) | $193.4M | $110.9M | $89.4M | $123.0M |
| Cash and equivalents (year end) | $18.9M | $34.1M | $32.4M | $12.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Trevi Therapeutics, Inc.
- Ticker
- TRVI (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New Haven, CT
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1563880
Frequently asked questions
What exchange is Trevi Therapeutics, Inc. listed on?
Trevi Therapeutics, Inc. trades on the Nasdaq under the ticker symbol TRVI.
What industry is Trevi Therapeutics, Inc. in?
Trevi Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Trevi Therapeutics, Inc. headquartered?
Trevi Therapeutics, Inc.'s business address on file with the SEC is in New Haven, CT.
When does Trevi Therapeutics, Inc.'s fiscal year end?
Trevi Therapeutics, Inc.'s fiscal year ends on December 31.